Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

Portal Hypertension

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

Ascites

Ascites

DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.

European radiology·2020

Same author

Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation.

Diagnostic and interventional imaging·2013

Same author

Spontaneous regression of focal nodular hyperplasia: a pathological report.

BMJ case reports·2012

Same author

Can elastometry be used for a better identification of cirrhosis?

Clinics and research in hepatology and gastroenterology·2011

Same author

[Expression of the elastic fibers components during the fœtal liver development].

Morphologie : bulletin de l'Association des anatomistes·2010

Same author

Human cirrhosis: monoclonal regenerative nodules derived from hepatic progenitor cells abutting ductular reaction.

Gastroenterologie clinique et biologique·2010

Same journal

[Treatment of chronic hepatitis B: adherence and safety].

Gastroenterologie clinique et biologique·2010

Same journal

[Long-term therapy for chronic hepatitis B in HIV co-infected patients].

Gastroenterologie clinique et biologique·2010

Same journal

[Analogs combination therapy in chronic hepatitis B: when and how?].

Gastroenterologie clinique et biologique·2010

Same journal

[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].

Gastroenterologie clinique et biologique·2010

Same journal

[HBsAg quantification: virological significance].

Gastroenterologie clinique et biologique·2010

Same journal

[Influence of treatment on long-term evolution of chronic hepatitis B].

Gastroenterologie clinique et biologique·2010

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Cirrhosis: what else?

C Balabaud¹, P Bioulac-Sage

¹Service d'Hépatologie, Hôpital St-André, CHU de Bordeaux, 33075 Bordeaux, France. charles.balabaud@chu-bordeaux.fr

Gastroenterologie Clinique Et Biologique

|June 12, 2010

Summary

This summary is machine-generated.

Cirrhosis, once considered irreversible, now shows early-stage reversibility. Defining fibrotic stages using imaging and biomarkers is crucial for understanding this complex liver disease.

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Related Experiment Videos

Last Updated: Jun 12, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Area of Science:

Hepatology
Liver Disease Pathophysiology
Medical Imaging

Background:

The term cirrhosis, established two centuries ago, historically defined end-stage, irreversible liver disease.
Current understanding recognizes a spectrum of liver disorders, with early stages of fibrosis potentially being reversible.
Accurate staging of liver fibrosis is essential for effective patient management.

Purpose of the Study:

To emphasize the importance of defining distinct stages of the fibrotic process in liver disease.
To highlight the need for integrating current knowledge of liver structure and function into disease classification.
To explore the potential of modern diagnostic tools in characterizing liver fibrosis.

Main Methods:

Review of historical definitions and current understanding of cirrhosis.
Integration of morphological data with emerging diagnostic modalities.
Consideration of advanced imaging techniques and non-invasive biomarkers.

Main Results:

The traditional definition of cirrhosis as irreversible is evolving.
Early-stage liver fibrosis may exhibit reversibility, challenging the historical perspective.
A heterogeneous nature of liver disease necessitates refined classification.

Conclusions:

A precise definition and staging of liver fibrosis are paramount.
Modern imaging and non-invasive biomarkers offer promising avenues for improved diagnosis and classification.
Revising the nomenclature for liver disease stages is crucial for reflecting current scientific understanding.